"Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data." by Anthony D D’Urzo

Selected Works of Robert DiGiovanni, DO, FACOI, FACR

Article

Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data.

International Journal of Chronic Obstructive Pulmonary Disease (2015)

Anthony D D’Urzo, University of Toronto
Edward M Kerwin, Clinical Research Institute of Southern Oregon, PC, Medford, USA.
Kenneth R Chapman, University Health Network
Marc Decramer, Katholieke Universiteit Leuven
Robert DiGiovanni, Novartis
Peter D’Andrea, Novartis
Huilin Hu, Novartis
Pankaj Goyal, Novartis
Pablo Altman, Novartis

Link

Disciplines

Publication Date

August 11, 2015

DOI

10.2147/COPD.S81266

Citation Information

Anthony D D’Urzo, Edward M Kerwin, Kenneth R Chapman, Marc Decramer, et al.. "Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data." International Journal of Chronic Obstructive Pulmonary Disease Vol. 10 Iss. 1 (2015) p. 1599 - 1612
Available at: http://works.bepress.com/robert-digiovanni/3/